Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Vaccinex

July 2026

Vaccinex Market Share Analysis for July 2026

Year Founded2001
Employees51 - 200
Annual Revenue< $1M
vaccinex.com
Vaccinex
Vaccinex (including company regionals)
  • vaccinex.com
    vaccinex.com
See more website traffic and engagement information

Total visits to Vaccinex's top domains

Understand Vaccinex market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Vaccinex's top domains

Analyze Vaccinex engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Vaccinex's top domains

See how Vaccinex keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Vaccinex

These are the website technologies, by industry, used by Vaccinex top domains

Advertising (2)

PubMatic

PubMatic

Content Management System (2)

WordPress

WordPress

Conversion & Analytics (2)

Google Analytics

Google Analytics

Email Services (2)

Microsoft Exchange Online

Microsoft Exchange Online

More Technologies

5

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Vaccinex

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVaccinex will attend event Alzheimer's Association International Conference on Jul 13th '26.Vaccinex to report new biomarker data and plans for Phase 2B clinical trial of Pepinemab in AD at the Alzheimer's Association International Conference in London on July 13, 2026.
NewsVaccinex is developing therapies for Alzheimer's, Huntington's disease, cancer, and autoimmune disorders.Vaccinex is developing therapies for Alzheimer's, Huntington's disease, cancer, and autoimmune disorders.
NewsVaccinex is developing pepinemab anti-SEMA4D antibody.Vaccinex, Inc. has announced a $60 million revenue-sharing agreement with Pepinemab Development Venture, LP to further develop its pepinemab anti-SEMA4D antibody in a larger phase 2b clinical trial for Alzheimer's disease.

See all Vaccinex signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.